We are live on ! Find out more
NRG

Nemes Rush Group Portfolio holdings

AUM $1.05B
1-Year Est. Return 30.08%
This Fund
S&P 500
This Quarter Est. Return
+13.96%
1 Year Est. Return
+30.08%
3 Year Est. Return
+95.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$699M
AUM Growth
+$78.2M
Cap. Flow
+$6.03M
Cap. Flow %
0.86%
Top 10 Hldgs %
33.65%
Holding
711
New
49
Increased
151
Reduced
133
Closed
44

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$11.2M
2
LLY icon
Eli Lilly
LLY
+$7.42M
3
UNP icon
Union Pacific
UNP
+$4.3M
4
MRK icon
Merck
MRK
+$1.57M
5
BBY icon
Best Buy
BBY
+$1.41M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$9.97M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.03M
3
IYT icon
iShares US Transportation ETF
IYT
+$3.9M
4
EW icon
Edwards Lifesciences
EW
+$3.86M
5
NVDA icon
NVIDIA
NVDA
+$2.14M

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Financials 14.76%
3 Healthcare 11.61%
4 Industrials 11.43%
5 Consumer Discretionary 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNV icon
301
Franco-Nevada
FNV
$40.6B
$41K 0.01%
344
– –
IRT icon
302
Independence Realty Trust
IRT
$3.93B
$41K 0.01%
2,540
– –
HYMB icon
303
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.1B
$40.6K 0.01%
+1,582
New +$40.2K
VMC icon
304
Vulcan Materials
VMC
$37.4B
$40.4K 0.01%
+148
New +$36.5K
IEI icon
305
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$40.3K 0.01%
348
– –
IEF icon
306
iShares 7-10 Year Treasury Bond ETF
IEF
$47.4B
$40.2K 0.01%
425
– –
PHG icon
307
Philips
PHG
$25B
$40.1K 0.01%
2,243
+179
+9% +$3.43K
HMC icon
308
Honda
HMC
$39.3B
$39.7K 0.01%
1,066
-309
-22% -$10.6K
TMUS icon
309
T-Mobile US
TMUS
$196B
$39.7K 0.01%
243
+236
+3,371% +$38.4K
ARES icon
310
Ares Management
ARES
$28.8B
$39.6K 0.01%
+298
New +$38.1K
COKE icon
311
Coca-Cola Consolidated
COKE
$13B
$38.5K 0.01%
460
– –
PFGC icon
312
Performance Food Group
PFGC
$18.1B
$38.4K 0.01%
+514
New +$37.8K
LIN icon
313
Linde
LIN
$236B
$38.4K 0.01%
83
– –
EOG icon
314
EOG Resources
EOG
$74.4B
$38K 0.01%
297
+2
+0.7% +$233
AZN icon
315
AstraZeneca
AZN
$267B
$37.9K 0.01%
280
-1
-0.4% -$132
BME icon
316
BlackRock Health Sciences Trust
BME
$567M
$37.3K 0.01%
900
– –
SAP icon
317
SAP
SAP
$207B
$37.3K 0.01%
191
– –
SPTS icon
318
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
$37.2K 0.01%
1,288
+776
+152% +$22.5K
CLX icon
319
Clorox
CLX
$12.1B
$37.2K 0.01%
243
-69
-22% -$10.3K
ACAD icon
320
Acadia Pharmaceuticals
ACAD
$4.45B
$37K 0.01%
2,000
– –
INCY icon
321
Incyte
INCY
$26B
$36.7K 0.01%
+645
New +$38.7K
IUSG icon
322
iShares Core S&P US Growth ETF
IUSG
$31B
$36.3K 0.01%
+310
New +$34.5K
ENB icon
323
Enbridge
ENB
$121B
$36.2K 0.01%
1,000
– –
GIS icon
324
General Mills
GIS
$20.1B
$35.7K 0.01%
510
-242
-32% -$15.8K
AVIV icon
325
Avantis International Large Cap Value ETF
AVIV
$1.97B
$34.7K 0.01%
642
+597
+1,327% +$30.8K
11 12
13
14 15

Similar funds

HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
SPC
Spirepoint Private Client Vero Beach, Florida $1.05B AUM 22.43% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
KA
Kintegral Advisory New York $1.06B AUM 24.93% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return

Nemes Rush Group's Q1 2024 Portfolio in Review

As of Q1 2024, Nemes Rush Group held 711 positions worth $699M, up 13% from $620M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Nemes Rush Group's Q1 2024 filing shows 49 new, 151 increased, 133 reduced and 44 closed positions. Its largest new stake was RB Global: 1,308 shares worth $99.6K. The largest sale was Medtronic, an estimated $9.97M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Nemes Rush Group's largest Q1 2024 buy was RB Global: 1,308 shares worth $99.6K.
  • Nemes Rush Group added most to Novo Nordisk in Q1 2024, an estimated $11.2M increase.
  • Nemes Rush Group's biggest Q1 2024 reduction was Medtronic, cutting an estimated $9.97M.
  • Nemes Rush Group fully exited Splunk Inc in Q1 2024, selling an estimated $955K.
  • Nemes Rush Group's ten largest holdings make up 34% of its $699M portfolio in Q1 2024.
  • Nemes Rush Group opened 49 new positions and closed 44 in Q1 2024.
  • Nemes Rush Group's portfolio value rose 13% quarter-over-quarter to $699M.

Based on Nemes Rush Group's 13F filing for Q1 2024, filed 15 May 2024.